Therefore, our findings, in conjunction with previous discoveries, suggest that the biochemical pathway involving IL-4, an anti-inflammatory factor, and IL-1β, a pro-inflammatory factor, may have therapeutic potential for managing IL-1β-induced depressive behavior However, more research is needed to fully understand the role of the interplay between inflammatory factors in the development of MDD. The gene discussed is IL1B; the disease is major depressive disorder.